Requires practitioners who administer naloxone or another overdose reversal agent to a patient in the case of a suspected or confirmed overdose to report the administration of the agent to the prescription monitoring program registry.
Relating to the prescription, administration, and possession of certain opioid antagonists for the treatment of suspected opioid overdoses, training about opioid antagonists and drug overdoses, and grants for related programs.